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The ability  of brucella  to localize and  remain viable within  the cells of an 
infected  host  must  be  considered  an  important  factor  in  explaining  the  re- 
lapses  following therapy  and  the tendency  toward  chronicity of this  disease. 
Experimental  evidence supporting  this concept has been provided by the ob- 
servation  of Magoffin and  Spink  (1)  that  intracellular  brucella  are protected 
in vitro against the lethal effect of therapeutic agents. In order to extend these 
observations  a  method  has  been  developed  which  permits  a  quantitative  in 
tritro study of the basic unit involved in brucellosis. This basic unit is a  viable 
host  cell  containing  viable  intracellular  bruceUa.  Exudative  leukocytes  con- 
taining  large  numbers  of intracellular  brucella  have been maintained  in ~itro 
in a  synthetic tissue culture medium, or in human or animal serum. The meth- 
ods used in these studies have permitted an evaluation of the effect of thera- 
peutic agents and the bactericidal action of animal or human serum on intra- 
cellular  brucella.  In  addition  the  metabolic  status  of  the  host  cell  has  been 
correlated with its ability to protect the intracellular organisms. The metabolic 
activity of both host cells and intracellular organisms has been investigated by 
direct  microscopic  observation  of  the  reduction  of  tetrazolium  salts  to  pig- 
mented formazans. 
Methods 
Adult, male white rats were injected intraperitoneally  with 8 ml. of sterile sodium caseinate 
to produce a peritoneal exudate. The sodium caseinate was prepared from pure casein by the 
method of Martin eta/. (2). 8 hours later 5 billion brucella organisms in 5 ml. of physiological 
saline solution were injected  into the peritoneal  cavity containing  the exudate  and  in v/vo 
phagocytosis allowed to proceed for 16 hours. Preliminary studies indicated that at the end of 
this time practically all the leukocytes in the exudate contained brucella and very few organ- 
isms remained in an extracellular position. The animal was then anesthetized and exsanguin- 
ated by cutting the large neck vessels. The skin of the abdomen was prepared with tincture 
of zephiran  1:1000 and the peritoneal cavity opened aseptically. 20 or 30 ml. of sterile he- 
parinized (1:5000) Simms -X7 solution  t was introduced into the peritoneal cavity through a 
All tissue culture media used in these studies were obtained from Microbiological Associ- 
ates, Inc., Bethesda. 
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3 cm. to 4 cm. incision. The Simms solution was mixed with the peritoneal exudate by gentle 
agitation of the animal and the suspension of leukocytes in Simms solution removed from the 
peritoneal cavity by aspiration.  2 ml.  of leukocyte suspension was distributed into each of 
two series of sterile, cotton-plugged, 15 ml. pyrex centrifuge tubes. The first series of tubes, 
designated as series A, was centrifuged at 1100 R.P.M. for 3 minutes, the superuatant decanted 
and discarded. The packed leukocytes were then washed by resuspending them in 2 ml. of 
heparinized Simms solution and again centrifuged for 3 minutes at II00 R.P.M. After discard- 
ing the supernatant the washed, packed leukocytes were resuspended in 2 ml. of a  synthetic 
tissue culture medium,  2 either as such or containing the therapeutic agent or agents to be 
tested for activity against intracellular brucella.  After  thorough mixing of  the leukocytes 
containing intracellular brucella in series A with the tissue culture medium, incubation was 
carried out at 37°C. for 24 hours with gentle agitation at frequent intervals. 
The second series of tubes, designated as series B, was handled in the same manner as 
series A except that the tubes were immersed in a water bath at 60°C. for 30 seconds before the 
leukocytes were washed and resuspended in the tissue culture medium. This exposure to heat 
was sut~cient to injure the leukocytes but left most of the intracellular brucella in a  viable 
state,  series B consisting of living bruceUa in heat-injured leukocytes served as a control for 
series A which consisted of viable brucella in viable leukocytes. "Zero-time brucella counts" 
to determine the number of viable brucella per milliliter of the final suspension of leukocytes, 
prior to exposure to test agents, were obtained immediately before the tubes were incubated. 
These brucella counts were made with an agar pour plate method in which 0.5 ml. of tenfold 
dilutions of the lenkocytic suspension in V-614 alone, from both series A and series B, were 
incorporated in trypticase soy agar  a or Albimi brucella agar  4. 
At the completion of the 24 hourperiod of incubation 1.0 ml. portions were removed from 
each tube in both series A and series B  and transferred to sterile, cotton-plugged centrifuge 
tubes. The leukocytes in these samples were washed several times by centrifuging and resus- 
pending them in sterile physiological saline to remove the test agents from the extracellular 
fluid. The washed leukocytes were finally resuspended in 1.0 ml. of sterile physiological saline. 
This suspension was then used to determine the "24 hour brucella counts" by the same agar 
pour plate method used to obtain the "zero-time brucella counts." After the period of incuba- 
tion of 24 hours, portions of the remaining 1.0 ml. of leukocytic suspensions in each tube of 
series A and series B were used to determine the per cent of viable leukocytes remaining in 
each tube, and to prepare heat-fixed spreads on glass slides for Macchiavello stains. A neutral 
red vital staining method as described by Diggs (3) was used to determine the per cent of 
viable leukocytes in each tube. Finally, the remaining leukocytes and the bmcella contained 
within them were exposed to neotetrazoUum chloride  s in concentrations of 0.003 to 0.0003 
per cent for 12 to 24 hours at 37°C. Following exposure to neotetrazolium the leukocytes were 
examined microscopically as either air-dried, heat-fixed spreads on glass slides or by placing a 
smaU drop of the lenkocytic suspension, which had been exposed to tetrazolium, on a clean 
glass slide and covering it with a coverslip. 
The bmcella organisms used in these studies were smooth, virulent strains originally iso- 
lated from the blood of patients with brucellosis and maintained in this laboratory for several 
years. The brucella suspensions injected into rats were prepared from the 24 hour growth of 
brucella on trypticase soy agar or Albimi brucella agar. 
The therapeutic agents tested singly or in combinations against intraceUular brucella in- 
Fischer V-614 medium, Microbiological Associates, Inc. 
a Baltimore Biological Laboratory, Baltimore. 
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cluded: streptomycin, aureomycin, terramycin, chloramphenicol, sodium sulfadiazine, sulfa- 
merazine, cortisone,  BAL  (2,3-dimercaptopropanol),  trypan  blue,  neopenil  (penicillin G 
diethylaminoethyl ester hydriodide), and erythromycin (ilotycin). Each agent was tested over 
a range of concentrations from those attainable in human subjects to the highest concentration 
which could be utilized in vitro. This upper limit was determined by the solubility of the 
agent, by its toxicity for the leukocytes, or by unphysiological shifts in pH in the tissue cul- 
ture medium. 
Studies on the bactericidal effect of human or animal serum on intracellular and extracellu- 
lar brucella were carried out in a slightly different manner. Leukocytes containing intracellular 
brucella were obtained from the peritoneal exudate of mice instead of rats. The exudate was 
produced by the intraperitoneal  injection of 1.0 ml. of sterile sodium caseinate, followed 8 
hours later by the intraperitoneal injection of one billion brucella. The suspension of intraeellu- 
lar brucella was collected 16 hours later as previously described. The sera used for these 
studies were obtained from rabbits or human subjects within 1 hour before the experiments 
were begun. The serum to be tested for bactericidal action was divided into  four sterile, cotton- 
plugged centrifuge tubes. The intracellular brucella organisms contained in the mouse leuko- 
cytes were added to and mixed with the serum in two of the tubes. Control suspensions of 
extracellular brucella organisms were prepared by adding bacteria from a 24 hour growth on an 
agar slant to physiological saline solution and then mixing the preparation with the  serum in 
the other two tubes. The number of viable intracellular brucella per milliliter of leukocytic 
suspension could not be determined prior to each experiment. However, preliminary studies 
indicated that 50 to 100 leukocytes per ml. of serum would, at "zero time," yield approximately 
the same number of viable brucella as the addition of 0.05 ml. of a saline suspension of brucella 
containing 50,000 organisms per ml. to each milliliter of serum. Aliquots from each tube for 
agar pour plate brucella counts were removed immediately after the mixing of the serum with 
the leukocytes or the serum with extracellular brucella, and at intervals up to 48 hours. The 
tubes were incubated at 37°C. during each experiment. 
~S~TS 
Vital  staining with  neutral red  or  tetrazolium indicated that  in Fischer's 
V-614 tissue culture medium 60 to 80 per cent of the leukocytes were still viable 
after 24 hours in vitro at 37°C. The leukocytes did not survive as well in Simms 
solution or in a  gelatin Tyrode solution. The survival time of leukocytes con- 
taining intracellular brucella was essentially the same as  that observed with 
leukocytes which did not contain brucella. The addition of therapeutic agents 
to the tissue culture medium had variable effects on the survival of leukocytes 
in vitro, depending on the agent used and the concentration of drug employed. 
In general, it was possible to test most of the currently available therapeutic 
agents in concentrations considerably above the levels which could be obtained 
in human subjects, without producing a  marked toxicity for the leukocytes. 
Macchiavello stains revealed that the peritoneal exudate produced by sodium 
caseinate consisted of approximately 60 to  70 per cent of polymorphonuclear 
neutrophile leukocytes with  the  rest  of  the  cells consisting of macrophages, 
monocytes, and lymphocytes. The monocytes and macrophages  consistently 
contained larger numbers of intracellular brucella per cell than  did  the  poly- 
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Effect of Therapeutic Agents on Intracellular Brucella 
None of the therapeutic agents tested $n ,itro, whether used singly or in com- 
binations, was capable of killing all the intracellular brucella within 24 hours. 
However, the most effective reduction in the number of living brucella present 
within viable  leukocytes was accomplished  by a  combination consisting  of 
streptomycin plus  one of the bacteriostatic antibiotics,  such as aureomycin, 
terramycin, or chloramphenicol. A remarkable protection of intracellular bru- 
cella against the lethal action of streptomycin is demonstrated by the data in 
Table I. Organisms from this strain of Brucdta suis suspended  in a  cell-free 
medium were killed by streptomycin in a concentration of 2 ~g. per ml.; yet 
considerable numbers of streptomylein-sensitive brucella  were recovered from 
leukocytes when exposed to streptomycin in concentrations of 50,000 vg. per 
TABLE I 
Effect of Streptomycin  on Intra, dlular Brucella suis 
Zero time bruceUa counts: Series A--7,930,000 
Series B--2,020,000 
Streptomycin  concentration 
lOOO 
100o0 
500o0 
Per cent viable 
leukocytes  (series A) 
75 
50 
26 
6 
24 hr. bmcella  counts 
Series A 
910,000 
151,000 
19,400 
13,300 
Series B 
20 
50 
26 
12 
ml. for 24 hours. The data in Table I also demonstrate that this protection of 
intraceUular brucella is dependent upon the presence of viable and intact leu- 
kocytes. Very few viable brucella  could be recovered from the tubes in series 
B in which the'leukocytes had been injured by heat prior to exposure to strep- 
tomycin. None of the leukocytes in series B was viable after 24 hours of ex- 
posure. In series A, 75 per cent of the leukocytes were viable after exposure to 
100 ~g. per ml. of streptomycin for 24 hours, indicating that this concentration 
of drug was not demonstrably toxic to the leukocytes.  The higher concentra- 
tions of streptomycin were progressively more toxic to the leukocytes so that 
few cells appeared to be viable after 24 hours' exposure to 50,000/~g. per ml. 
Data are presented in Table II demonstrating the superiority of a combined 
type of therapy against intracellular brucella.  Streptomycin plus  terramycin 
or chloramphenicol was much more effective in reducing the number of viable 
intracellular brucella than was streptomycin alone or streptomycin plus sulfa- 
merazine. Here again, injury to the leukocytes by heat markedly reduced the 
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series A was essentially the same for all four groups so that the increased effec- 
tiveness of the combined therapy could not be attributed to any obvious differ- 
ences in toxicity of the drugs for the host cell. 
Attempts to augment the action of streptomycin or other therapeutic agents 
against intracellular brucella were unsuccessful. Streptomycin plus trypan blue 
was little more effective than was streptomycin alone. The addition of BAL 
in concentrations of 5 ~g. per ml. to streptomycin or chloramphenicol did not 
alter  the  activity of  these  drugs  against  intracellular brucella.  Cortisone  in 
concentrations of 25 ~g. or 50 ug. per ml. had no significant effect on the kill- 
TABLE II 
Effect of Streptomycin Alone and When Combined with Other Drugs on Intracellular 
Brucella suis 
Zero time brucella counts: Series A--3,380,000 
Series B--2,150,000 
Drug and concentration 
,g.ml. 
Streptomycin--50 
Streptomycin--50 
Terramycin--50 
Streptomycin--50 
Chloramphenicol--50 
Streptomycin--50 
Sulfamerazine--500 
Per cent viable 
ieukocytes 
(series A) 
76 
76 
72 
86 
24 hr. brucell~ counts 
Series  Series 
A  B 
389,000  910 
79,000  1430 
50,000  870 
221,000  2570 
ing of intracellular brucella by streptomycin. Neopenil was no more effective 
against  a  penicillin-sensitive  strain  of  intracellular  Brucella  abortus  than  an 
equivalent concentration of crystalline penicillin G. Erythromycin in concen- 
trations up to 100 ~g. per ml. was no more effective against intracellular bru- 
cella than was streptomycin. Erythromycin was quite toxic for leukocytes in 
vitro  in  concentrations above  100  ~g.  per  ml.  Aureomycin,  terrkmycin,  or 
chloramphenicol alone in concentrations of 50 ug. to 100 ~g. per ml. had  some 
lethal activity against intracellular brucella. However, this  antibrucella effect 
was  much  less  pronounced  than  equivalent  concentrations  of  streptomycin 
alone, and  the essential action of these drugs was to suppress multiplication 
of the bacteria rather than to kill them. The methods used in these studies did 
not permit an evaluation of the effect of prolonged bacteriostasis on intracellu- 
lar brucella. However, other studies in vivo (4) have shown that viable brucella 82  PROTECTION  OF  BRUCELLA  AGAINST  THERAPEUTIC  AGENTS 
may be recovered from the  tissues of mice treated  continuously for 3  weeks 
with aureomycin or terramycin. 
Bactericidal Effect of Serum on Intracellular and Extra, cellular Brucella 
The  protection  of  intracellular  brucella  against  the  bactericidal  action  of 
fresh rabbit serum or human serum is demonstrated in Text-fig.  1. With  the 
sera  used  in  these  experiments  extracellular  brucella  were  rapidly  killed 
so that only about 10 to 15 per cent of the organisms survived 6 hours' exposure 
to the sera in vitro at 37°C. No viable extracellular brucella could be recovered 
~00 
90 
80 
Rabbit  serum 
Brucella  ogglutinin  titer  0 
Humon  serum 
8rucello  ogglutinin  titer  atypical  1:40 
_o  70 
o  50 
>  40 
g 
~•  e.=-,e Extracellulor  brucello 
o,,.-o Intracellular  brucella 
(in  mouse  leukocytes) 
~o 
% 
0 
2  6  12  24  48  2  12 
Time  in  hours 
•% 
"% 
•q 
!• 
•%1 
b% 
6  24  48 
TExx-FIO. 1. Bactericidal effect of serum on intraceUular and extracellular Brueella abortus 
in vitro. 
from these sera after exposure at 37°C. for 24 hours. On the other hand, intra- 
cellular brucella were killed by these sera much more slowly.  After 6  hours, 
about 80 to 85 per cent of the intracellular brucella were still viable. After 24 
hours, between 40 and 50 per cent of the intracellular brucella were still alive. 
The human serum used in this experiment was obtained from the blood of an 
individual who was considered to be relatively immune  to brucella infection. 
He had never had clinical evidence of brucellosis but he had been  repeatedly 
exposed to infection in the laboratory over a period of 3 years. At one time his 
serum had shown a  brucella agglutinin  titer of  1:160.  The bactericidal power 
of human serum  was found  to differ from one individual  to another.  Serum 
from another individual  who had  had brucellosis about 3  months previously 
was found to have a  very weak bactericidal effect against either  extracellular 
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of testing was 1:160. With serum from this convalescent human case of brucel- 
losis 80 per cent of the added extracellular brucella survived exposure for 12 
hours at 37°C. No bactericidal effect on intracellular brucella could be demon- 
strated with  this serum when leukocytes containing the  organisms were ex- 
posed to the serum in vitro for 24 hours. At the end of 48 hours,  70 per cent of 
the intracellular brucella were still viable. Hall (5) has noted similar variations 
in the bactericidal action of human serum on extracellular brucella as well as a 
reduced bactericidal action of undiluted  serum following the acute  phase of 
human brucellosis. The observations that intracellular brucella are  protected 
against  the bactericidal action of serum shed  some  light  on  the  mechanism 
whereby a brucella infection can persist despite the presence of a  highly effec- 
tive humoral defense mechanism. 
Reduction of Tetrazolium Salts  by Leukocytes and Brucella 
Preliminary investigations indicated that neotetrazolium chloride (NT) was 
more satisfactory for the purposes of this study than was  2,3,5-triphenyltet- 
razolium hydrochloride (TPT). The intense  purple-black formazan produced 
by the reduction of NT facilitated the  microscopic observation of leukocytes 
and brucella. The orange-red formazan resulting from  the reduction of TPT 
was found to be less stable and more lipoid-soluble. In addition  the pigmenta- 
tion  of both  leukocytes and  brucella  by the TPT formazan  was  much less 
intense than by the NT formazan. For these reasons the use of TPT was aban- 
doned and subsequent studies performed only with NT. 
Viable  exudative leukocytes maintained  in  V-614  tissue  culture  medium 
rapidly reduced NT in vitro at 37°C. This reduction of NT by a suspension of 
viable leukocytes was visible in the gross as a red-purple color which became 
purple-black with  time. The rapidity with which this gross  color change oc- 
curred  depended upon  the  concentratian of NT and  the  per  cent of viable 
leukocytes. It was found that when a  concentration of NT of 0.003 per cent 
was in contact with bacteria or leukocytes for 12 to 24 hours, a maximum re- 
duction of NT occurred and in this manner the  metabolic activity of leuko- 
cytes by direct microscopic observation  could  be  assessed.  Microscopically, 
viable  leukocytes produced  intense  purple-black  granules  within  the  cyto- 
plasm or long sheaf-like crystals (Fig.  1). The ability of leukocytes to reduce 
NT decreased with  time as  the  cells were maintained  in vitro. Over 95  per 
cent of the fresh exudative leukocytes exposed to 0.003 per cent NT in vitro 
produced the characteristic formazan granules within the cytoplasm. After 24 
hours in vitro from 60 to 80 per cent of the leukocytes were still capable of 
producing formazan granules. With  these and other intermediate time inter- 
vals the per cent of leukocytes manifesting metabolic activity, as reflected by 
purple-black  formazan production,  closely corresponded  to  the  per  cent  of 
leukocytes interpreted to be viable by the neutral red vital-staining method. 84  PROTECTION  OF BRUCELLA  AGAINST THERAPEUTIC  AGENTS 
Heat-injured ~eukocytes did not reduce NT, nor did exposure to neutral red 
indicate viability. These observations revealed that NT reduction by leuko- 
cytes in ~itro provided a reliable method for assessing the metabolic activity of 
an individual leukocyte. If a leukocyte on microscopic examination contained 
formazan granules it was considered to be exhibiting metabolic activity and to 
be viable. If the leukocyte did not exhibit formaz',kn granules it was considered 
to be non-viable. 
There was a  variable reduction of NT by brucelia populations. A  24 hour 
broth culture of brucella exposed to 0.003 per cent NT for 12 to 24 hours and 
subsequently examined microscopically exhibited all degrees of formazan pro- 
duction from no evidence of reduction to large purple-black granules within 
the bacterial cells, associated with a bizarre, swollen, and distorted appearance 
(Fig.  2).  Perhaps  the most  characteristic  appearance  of brucella  organisms 
exposed to NT was a cell containing one large, round, black unipolar granule. 
Heat-killed or phenol-killed brucella did not reduce NT.  Some brucella  ex- 
posed to lethal concentrations of streptomycin for as long as 48 hours retained 
their ability to reduce NT (Fig. 3). This reducing power was exhibited by rela- 
tively few cells in a bacterial population in which there were no viable organ- 
isms as determined by the usual cultural methods. Exposure of brucella to 
high concentrations of aureomycin, terramycin, or chloramphenicol for as long 
as 48 hours had little effect on the ability of the bacteria  to reduce NT (Fig. 
4). Exposure of brucella in ~itro to streptomycin plus one of the broad spectrum 
antibiotics decreased but did not completely prevent NT reduction by some of 
the bacteria. Phagocytosis of brucella did not significantly alter their ability 
to  reduce  NT.  Viable  leukocytes containing large  numbers  of intracellular 
brucella when exposed to NT for 12 to 24 hours and then examined micro' 
scopically presented a  characteristic appearance (Fig. S). In such leukocytes 
the larger black granules resulting from the metabolic activity of the host 
cell could usually be easily distinguished from the smaller black granules within 
the cell bodies of individual intracellular brucella. Not all intracellular brucella 
reduced NT however, and it was not possible to assess the metabolic activity 
of the individual intracellular organism on the basis of formazan production 
alone. 
Reduction of NT by leukocytes and brucella has provided a method apply- 
ing both to the host cell and the intracellular parasite. From the available evi- 
dence it would appear  that formazan production by a  leukocyte is  closely 
related to those vital processes which are indicated by the characteristic ap- 
pearance of viable leukocytes stained with neutral red. On the other hand it 
has not been possible to demonstrate a  consistent, clear cut relationship be- 
tween the viability of brucella and their ability to reduce NT. The tetrazolium 
technique as applied in these studies has permitted microscopic examination 
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ance of the leukocyte it has been possible to estimate the metabolic  activity 
of the host cell, but it has not been  possible to distinguish a  viable  from a 
non-viable intracellular organism with any degree of certainty. 
DISCUSSION 
The ability of brucella  to localize and remain viable within the cells of an 
infected host appears to explain the tendency toward chronicity of this disease. 
It also explains the difficulty experienced in completely  eradicating these or- 
ganisms from the tissues by the administration of therapeutic agents.  These 
studies and the observations of Magoflin and Spink (1) have shown that intra- 
cellular brucella are much less susceptible to the lethal effect of drugs than are 
extracellular  brucella.  These studies have also provided additional evidence 
supporting the clinical and experimental  observations  that the most effective 
therapy against brucella infections is a combined type of therapy with strepto- 
mycin plus aureomycin, terramycin, or chloramphenicol. It has also been pos- 
sible to demonstrate that intracellular brucella are protected against the bac- 
tericidal  action of serum, one of the few known mechanisms in brucellosis by 
which animals or man may prevent invasion of the tissues by brucella or over- 
come the infection once it has become established. This protective phenomenon 
of intracellular organisms is not unique for brucella.  In 1916 Rous and Jones 
(6)  demonstrated such protection with intracellular typhoid bacilli and more 
recently Barski (7), Mackaness (8, 9), and Suter (10) have shown that intra- 
cellular tubercle bacilli are protected against the lethal action of streptomycin. 
The studies reported here deal only with brucella contained within leukocytes 
maintained in vitro and cannot be assumed to reflect the role of the cells of the 
reticulo-endothelial  system in brucellosis. The role of a cellular mechanism  in 
the ultimate eradication of a  brucella  infection,  if such  exists, has not been 
demonstrated. From the present studies it would appear that phagocytosis  of 
brucella  by leukocytes did not kill the bacteria, nor did the presence of large 
numbers of organisms within the leukocytes injure the host cell. From these 
and other studies in experimentally infected animals the following concept of 
brucella infection can be derived:-- 
(a)  Intracellular localization  of brucella  by phagocytosis  favors the host 
by clearing the blood stream and localizing the infection. 
(b)  This intracellular localization  of brucella  favors the bacteria by main- 
taining them in a viable state and protecting them against attempts to eradi- 
cate the infection from the tissues. 
(c)  This biologic phenomenon accounts,  at least in part,  for the relative 
ineffectiveness of therapeutic agents or humoral defense mechanisms "m brucel- 
losis and the tendency toward chronicity of the disease. 
The teArazolium  aspect of this study was stimulated by the reports indicating 
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living tissues including leukocytes and bacteria  (11-14).  It was  anticipated 
that viable leukocytes could be differentiated from non-viable leukocytes, and 
living from dead intracellular brucella by direct microscopic observation. This 
anticipation was not completely realized, but the tetrazolium studies did yield 
some provocative results relative to the effects of the antibiotics on brucella. 
Streptomycin, which is bactericidal for brucella in vitro, produced a quantita- 
tive reduction in the number of individual organisms capable of reducing neo- 
tetrazolium. Nevertheless,  there were always a  considerable number of bru- 
celia which, though non-viable on culture, apparently killed by streptomycin, 
were still able to produce intensely dark formazan granules in the presence of 
NT.  The  bacteriostatic  antibiotics,  aureomycin,  terramycin,  and  chloram- 
phenicol produced little alteration in  the  ability of brucella  to  reduce NT. 
These observations suggest that if the bacteriostatic mechanism of these drugs 
acts  through inhibition of an enzyme system within the  bacterial  cell,  that 
enzyme system is not the one involved in the reduction of NT. Evidence that 
bacterial viability may be destroyed before the ability of the organism to re- 
duce  the  tetrazolium  salts  is  lost  has  also  been  demonstrated  by  Bielig, 
Kausche, and Haardick (12).  These investigators showed that formazan pro- 
duction by bacteria was not reduced by heat until a temperature 10  ° above the 
thermal death point for almost all the organisms was reached. They also showed 
that in old, resting cultures of Escherichia coli and Salmonella  50 to 80 per cent 
of the organisms showed no visible formazan granules. That these organisms, 
which did not reduce tetrazolium, were still viable was demonstrated by trans- 
ferring the bacteria to fresh media in which active mitosis occurred. It therefore 
appears that the ability or inability of bacteria to reduce the tetrazolium salts 
is not necessarily synonymous with viability or nonviability of the organisms. 
Brucellosis in man or animals is usually a  self-limiting disease and the ma- 
jority of brucella infections will eventually be controlled or eradicated by the 
host  without specific  therapy.  The  mechanisms by which  this  clearance  of 
brucella is accomplished are still not clear. Humoral and cellular mechanisms 
both may be involved. It is known that the bactericidal action of blood or 
serum can be increased by an infection or immunization of animals (15-16). 
However, unless brucella cells become accessible  to the action of blood, such an 
increase in the bactericidal action of the humoral defenses would be relatively 
ineffective. Circulating phagocytes appear to have little, if any, lethal effect 
on the brucella which become localized within these cells.  But, Braude  (17) 
has noted that in experimentally infected animals it was difficult to demon- 
strate brucella in the cells of the granulomas after the 5th day, indicating that 
within a relatively short time most of the brucella had been disposed of by the 
host. It was also his impression that a  predominance of mononuclear cells in 
the granulomas was associated with a  favorable course of the disease in the 
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system may exert a lethal effect on brucella in vivo. On the other hand, brucella 
can commonly be cultured from tissues in which no organisms can be seen 
microscopically, suggesting that only a  balance between host and parasite  is 
achieved rather than complete eradication of the parasite. Another possibility 
is that cells of a  certain type may be primarily involved in perpetuating bru- 
celia infections. Goodpasture (18)  has implicated the plasma cell as a  factor 
in the chronic or carrier-type of typhoid infection. There is at present, however, 
no  evidence that  such  a  specific  host-cell-brucella  relationship  exists as an 
explanation for the tendency toward chronicity in brucellosis. Investigations 
to date, then, have not clarified to any great extent the relative importance of 
humoral or cellular mechanisms in the control and eradication of brucella in- 
fections. The studies reported here only indicate that the effectiveness of extra- 
cellular factors is reduced by the protection afforded intracellular brucella. 
It was repeatedly observed in these studies that streptomycin would kill 
many, but  not all,  of the  intracellular brucella  contained within exudative 
leukocytes. It was also observed that, within the range of concentrations non- 
toxic for leukocytes, increasing the concentration of streptomycin reduced the 
number of surviving intracellular organisms. These observations would indicate 
that streptomycin does penetrate  to some extent into  the leukocytes. Why 
then are some intracellular brucella protected against much higher concentra- 
tions of streptomycin? Our  observations suggest  two possible  explanations. 
First, it could be postulated that streptomycin penetrates one or more types of 
leukocytes more  effectively than  other  types.  For  example,  the  organisms 
within polymorphonuclear leukocytes might be killed by streptomycin more 
readily than those contained within monocytes. The only evidence supporting 
this hypothesis is the observation that the few leukocytes which survived ex- 
posure  to  the highest concentrations of streptomycin tested appeared  to be 
monocytes, and from those few surviving leukocytes considerable numbers of 
living brucella  were recovered.  A  second possible  explanation is  that  when 
brucella localize within a  cell both physical and chemical changes may occur 
which alter the ability of streptomycin to exert a lethal effect on the organisms. 
It was also frequently observed in these studies that brucella were not uncom- 
monly localized within compartments in the leukocytes. Braude has observed 
a  similar phenomenon within the histiocytes of experimentally infected ani- 
mals (19). It would seem possible that such a "cell within a cell" situation could 
protect  those brucella  within a  compartment more  effectively and  decrease 
the activity of an agent such as streptomycin. 
The observation that streptomycin plus aureomycin, terramycin, or chlor- 
amphenicol was more effective in reducing the number of viable intracellular 
brucella organisms than any one drug alone is in agreement with a number of 
experimental and clinical reports (19-23). Earlier studies from this laboratory 
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on brucella  in  experimentally infected chick  embryos. The results  of these 
studies  on  intracellular brucella  also  indicate  that  the  combined action  of 
streptomycin and one of the bacteriostatic agents is more than just an additive 
effect. 
SUmmARY AND COnCLUSIOnS 
A method for the in vitro study of intraceUular brucella has been described. 
Exudative leukocytes containing intracellular brucella have been maintained 
in vitro in a synthetic tissue culture medium or in human or animal serum. 
Intracellular brucella are protected in vitro against the lethal action of thera- 
peutic agents or the bactericidal action of serum. This protection of intracel- 
lular brucella is dependent upon the presence of an intact, viable host cell. 
None of the currently available therapeutic agents, whether used alone or 
in combinations, were capable of killing all intraceUular brucella in vitro  in 24 
hours. A remarkable protection of intraceUular brucella against streptomycin 
has been demonstrated. The most effective reduction in the number of viable 
intracellular brucella was  accomplished by exposure of the host cells to strep- 
tomycin plus aureomycin, terramycin, or chloramphenicoh 
The available evidence suggests that the ability of brucella to localize and 
remain viable within the cells of an infected host is an important biologic factor 
in establishing and perpetuating brucella infections, despite therapeutic meas- 
ures or the operation of the host's humoral defense mechanisms. 
Reduction of neotetrazolium by leukocytes and bruceUa  in vitro provides a 
method for assessing the metabolic status of the host cell, but does not dis- 
criminate with any degree of certainty a viable from a non-viable intracellular 
organism. 
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EXPLANATION OF PLATE 4 
FIG.  1.  Formazan  granules  within  the  cytoplasm  and  crystals  produced  by 
exudative leukocytes which were maintained  in a  synthetic tissue  culture  medium 
for 12 hours before exposure to neotetrazolinm chloride.  ×  500. 
FIG.  2.  Reduction of neotetrazolium by a  24 hour broth culture of Brucd/a  su~s. 
Note variation in the shape, size, and intensity of staining of individual  organisms. 
X 950. 
FIG.  3.  Reduction of NT by Brucella suis exposed to streptomycin (100  /~g. per 
ml.) for 48 hours. No viable brucella could be recovered from this preparation before 
exposure to NT.  X 950. 
FIG.  4.  Reduction of BIT by Brucella suis exposed to chloramphenicol (100/zg. per 
ml.) for 48 hours. Viable brucella recovered from this preparation before exposure to 
NT.  X  950. 
FIO.  5.  NT  formazan production  by a  large  leukocyte  containing  many  intra- 
cellular brucella  (center).  Adjacent leukocytes show less  formazan production indi- 
cating fewer intracellular  organisms (lower center)  and less  metabolic activity (left 
upper).  X  500. THE  JOURNAL OF  EXPERIMENTAL  MEDICINE  VOL. 97  PLATE  4 
(Shaffer et al.: Protection of brucella against therapeutic agents) 